Raytheon Technologies Corp vs Tilray Brands Inc — how do they compare? Raytheon Technologies Corp trades at $223.51 (market cap $302.06B), while Tilray Brands Inc trades at $4.74 (market cap $601.34M). The key difference: Raytheon Technologies Corp is far larger — about 502.3× Tilray Brands Inc's market cap, and Raytheon Technologies Corp pays a 1.3% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| RTX | TLRY | |
|---|---|---|
Market Cap | $302.06B | $601.34M |
Sector | Industrials | Health |
52-Week High | $224.12 | $21.00 |
52-Week Low | $151.75 | $3.88 |
Enterprise Value | $332.61B | $768.47M |
Dividend Yield | 1.3% | — |
Signals from Pluang's Aura AI — not financial advice
RTX trades at $223.86, up 0.37% today, with a bullish technical signal and strong analyst consensus of 17 buys and a $233.14 price target. Recent earnings beats and a $515 million Navy radar contract (PRNewsWire, June 3, 2026) highlight operational momentum. Revenue grew to $88.60 billion in 2025, with net income margin improving to 8.28%, though a P/E of 39.46 suggests premium valuation.
The outlook is positive, driven by defense contract wins and earnings growth, but risks include high valuation and geopolitical dependencies. Cash flow trends show strengthening operations, supporting dividend payments and strategic investments.
TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.
Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.
Trailing returns across standard periods
Latest headlines on both assets
Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.
Read more on RTX →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →